首页> 外文期刊>Cancer biology & therapy >Calcium calmodulin dependent kinase kinase 2-a novel therapeutic target for gastric adenocarcinoma
【24h】

Calcium calmodulin dependent kinase kinase 2-a novel therapeutic target for gastric adenocarcinoma

机译:钙钙调蛋白依赖性激酶激酶2-胃腺癌的新型治疗靶点

获取原文
获取原文并翻译 | 示例
           

摘要

Gastric cancer is one of the most common gastrointestinal malignancies and is associated with poor prognosis. Exploring alterations in the proteomic landscape of gastric cancer is likely to provide potential biomarkers for early detection and molecules for targeted therapeutic intervention. Using iTRAQ-based quantitative proteomic analysis, we identified 22 proteins that were overexpressed and 17 proteins that were downregulated in gastric tumor tissues as compared to the adjacent normal tissue. Calcium/calmodulin-dependent protein kinase kinase 2 (CAMKK2) was found to be 7-fold overexpressed in gastric tumor tissues. Immunohistochemical labeling of tumor tissue microarrays for validation of CAMKK2 overexpression revealed that it was indeed overexpressed in 94% (92 of 98) of gastric cancer cases. Silencing of CAMKK2 using siRNA significantly reduced cell proliferation, colony formation and invasion of gastric cancer cells. Our results demonstrate that CAMKK2 signals in gastric cancer through AMPK activation and suggest that CAMKK2 could be a novel therapeutic target in gastric cancer.
机译:胃癌是最常见的胃肠道恶性肿瘤之一,与预后不良有关。探索胃癌蛋白质组学格局的变化可能为早期发现提供潜在的生物标记,并为靶向治疗提供分子。使用基于iTRAQ的定量蛋白质组学分析,与邻近的正常组织相比,我们在胃肿瘤组织中鉴定了22种过表达的蛋白和17种下调的蛋白。发现钙/钙调蛋白依赖性蛋白激酶激酶2(CAMKK2)在胃肿瘤组织中过度表达了7倍。肿瘤组织微阵列的免疫组织化学标记可验证CAMKK2过表达,表明它确实在94%(98中的92%)胃癌病例中过表达。使用siRNA沉默CAMKK2可显着降低胃癌细胞的增殖,集落形成和侵袭。我们的结果表明CAMKK2通过AMPK激活在胃癌中发出信号,并提示CAMKK2可能是胃癌的新型治疗靶点。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号